Michael Matson
Stock Analyst at Needham
(2.29)
# 2,676
Out of 5,241 analysts
23
Total ratings
64.29%
Success rate
5.31%
Average return
Main Sectors:
Stocks Rated by Michael Matson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TFX Teleflex | Maintains: Buy | $408 → $423 | $130.41 | +224.36% | 4 | Jan 31, 2020 | |
| INGN Inogen | Upgrades: Buy | $90 | $6.30 | +1,328.57% | 2 | Nov 6, 2019 | |
| MMSI Merit Medical Systems | Initiates: Buy | $53 | $63.71 | -16.80% | 1 | Apr 20, 2018 | |
| GMED Globus Medical | Upgrades: Buy | n/a | $78.93 | - | 1 | Apr 4, 2018 | |
| RMD ResMed | Upgrades: Hold | n/a | $204.15 | - | 1 | Jan 23, 2018 | |
| BSX Boston Scientific | Upgrades: Strong Buy | n/a | $55.92 | - | 1 | Dec 8, 2017 | |
| KTWO K2 Capital Acquisition | Downgrades: Buy | n/a | $9.99 | - | 2 | Dec 8, 2017 | |
| LIVN LivaNova | Upgrades: Buy | n/a | $72.23 | - | 2 | Sep 15, 2017 | |
| SYK Stryker | Upgrades: Hold | n/a | $313.22 | - | 4 | Aug 25, 2017 | |
| MBLY Mobileye Global | Downgrades: Hold | n/a | $9.34 | - | 1 | Mar 14, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $62.25 | - | 1 | Aug 12, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.23 | - | 1 | Mar 3, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $5.15 | - | 1 | Feb 24, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $1,333.01 | - | 1 | Jan 29, 2016 |
Teleflex
Jan 31, 2020
Maintains: Buy
Price Target: $408 → $423
Current: $130.41
Upside: +224.36%
Inogen
Nov 6, 2019
Upgrades: Buy
Price Target: $90
Current: $6.30
Upside: +1,328.57%
Merit Medical Systems
Apr 20, 2018
Initiates: Buy
Price Target: $53
Current: $63.71
Upside: -16.80%
Globus Medical
Apr 4, 2018
Upgrades: Buy
Price Target: n/a
Current: $78.93
Upside: -
ResMed
Jan 23, 2018
Upgrades: Hold
Price Target: n/a
Current: $204.15
Upside: -
Boston Scientific
Dec 8, 2017
Upgrades: Strong Buy
Price Target: n/a
Current: $55.92
Upside: -
K2 Capital Acquisition
Dec 8, 2017
Downgrades: Buy
Price Target: n/a
Current: $9.99
Upside: -
LivaNova
Sep 15, 2017
Upgrades: Buy
Price Target: n/a
Current: $72.23
Upside: -
Stryker
Aug 25, 2017
Upgrades: Hold
Price Target: n/a
Current: $313.22
Upside: -
Mobileye Global
Mar 14, 2017
Downgrades: Hold
Price Target: n/a
Current: $9.34
Upside: -
Aug 12, 2016
Downgrades: Hold
Price Target: n/a
Current: $62.25
Upside: -
Mar 3, 2016
Downgrades: Neutral
Price Target: n/a
Current: $1.23
Upside: -
Feb 24, 2016
Downgrades: Hold
Price Target: n/a
Current: $5.15
Upside: -
Jan 29, 2016
Upgrades: Buy
Price Target: n/a
Current: $1,333.01
Upside: -